Beta Pharmaceuticals "Carbon 14 Marking Technology Service" Approved "Wuxi High-tech Products (Services)"

Release time:

2023-02-28

Through the procedures of enterprise declaration, local recommendation, expert review, comprehensive review, and discussion and decision by the party group meeting of the Municipal Science and Technology Bureau,Recently,WUXI BETA PHARMACEUTICAL TECHNOLOGY CO., LTD-"Carbon14 Marking Technology Services"ApprovedWuxi Science and Technology Bureau“Wuxi high-tech products (services)”.

Carbon14（C14）Mark Technical Services Industry"Isotope technology and its application" is an important part of the "light industry"-civil non-power nuclear technology (nuclear technology application), which is widely used in the field of atomic energy and nuclear energy, and is an important aspect of the peaceful use of nuclear energy. It is mainly used to label small molecule drugs and pesticides or bioactive molecules, so as to carry out drug generation, clinical, environmental and disease detection research. Beta Medicine'sC14 Marking Technology Service Breaks Our CountryC14 Mark to go abroad to do the situation. So far, it has provided marking services for nearly 200 innovative pharmaceutical and pesticide compounds, such as more than 100 listed companies, leading enterprises, industry rookies, scientific research institutes, and so on. None of the projects have failed and have been widely praised by the industry. it has strongly promoted the research and development process of innovative medicine and pesticide in China. On January 29, 2023, Beta Pharmaceuticals was approved by the State Food and Drug Administration for the listing of a class 1 innovative drug for the treatment of the new coronavirus, the deuterium hydrobromide and Remidvir tablets (trade name: Mindewei), which provides C14 labeling services to Junshi Bio, a listed company on the board of science and technology. August 2022, Beta Pharmaceuticals for the first time to the U.S. pharmaceutical giant.ExportC14 key precursor compounds have achieved a breakthrough in the export of C14 key precursor compounds in China, and also opened up the path for C14 marked products to be exported to overseas markets.

Focus on achievement excellence, innovation to lead the future.BetaMedicineHas been taking technological innovation and product innovation as the development conceptWe will make persistent efforts, continue to improve and innovate, and are committed to providing customers with high-quality products and services., letC14 isotope technology better benefit human health and ecological environmental protection.

None

Beta Pharmaceuticals was approved to build "Wuxi Engineering Technology Research Center"

None

Beta Pharmaceuticals was approved to build "Wuxi Engineering Technology Research Center"

Beta Pharmaceuticals "Carbon 14 Marking Technology Service" Approved "Wuxi High-tech Products (Services)"

Beita